Scientists Develop Quick Test To Assess Risk Of Developing Severe COVID-19 - Report
Muhammad Irfan Published December 07, 2021 | 03:56 PM
A group of American scientists developed a one-minute blood test that allows to assess immune responses in patients with COVID-19 and predict the severity of symptoms they will manifest, according to a report published by the journal Nature
MOSCOW (UrduPoint News / Sputnik - 07th December, 2021) A group of American scientists developed a one-minute blood test that allows to assess immune responses in patients with COVID-19 and predict the severity of symptoms they will manifest, according to a report published by the journal Nature.
The research analyzed the immune response dynamics in samples gathered from 153 COVID-19 patients and 142 healthy subjects. The results showed that in severe cases of COVID-19, patients' immune responses were skewed towards type 2 antibody-mediated immunity, while in asymptomatic or mild cases, patients had stronger type 1 cell-mediated immunity.
The two types of immunity together form the human body's defense system against infectious pathogens, especially intracellular pathogens such as viruses. When the frontline type 1 immune response fails, the type 2 initiates and neutralizes the virus by producing virus-specific antibodies. Measuring the relative balance of type 1 and type 2 immune responses allows to predict the clinical severity of viral infections, including COVID-19.
The testing method was previously tried on animals using a gold nanoparticle to simulate a virus pathogen and observe immune responses.
"Based on these animal studies, we hypothesize that the... immunity test may be able to detect the immune status change in COVID-19 patients. Furthermore, if the clinical severity of the COVID-19 patients is associated with the relative balance between the type 1 versus type 2 immunity, the test may be able to detect this difference and the result may be used to predict the clinical risk of the patients," the report said.
The proposed test requires blood samples obtained from finger prick and produces the result in less than a minute. However, the researchers said more extensive clinical studies are needed to further validate the test.
Recent Stories
Mired in crisis, Boeing reports another loss
Session Awarding Ceremony 2024 held at Cadet College Muzaffarabad
Austrian ski great Hirscher to make comeback under Dutch flag
Pakistan, Japan agrees to convene 'Economic Policy Dialogue'
FM Dar conveys deepest sympathy on torrential rains devastation in UAE
Spain PM Sanchez says weighing resignation after wife's graft probe
Tennis: ATP/WTA Madrid Open results - 1st update
Long-lost Klimt portrait auctioned off for 30 mn euros
Osaka seals first win on clay since 2022 in Madrid
Earthquake jolts Karachi
Sindh minister orders operation after attack on police in Ghotki
TikTok to fight US ban law in courts
More Stories From Health
-
Vaccines save at least 154 million lives in 50 years: WHO
9 hours ago -
UHS to issue MBBS degrees within three months after final result
12 hours ago -
Rawalpindi woman gives birth to six babies
5 days ago -
DC calls for intensive anti-polio drive in ICT
6 days ago -
World Hemophilia Day observed to underscore importance of providing comprehensive care
7 days ago -
Six in a family with heart on the 'right side'
7 days ago
-
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
7 days ago -
World Hemophilia Day observed
7 days ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
15 days ago -
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
15 days ago -
Health activists express concerns over attempts to derail tobacco control
17 days ago -
UHS declares MBBS first prof, MS urology exam results
26 days ago